TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts
Authors
Keywords
Growth inhibition, Neuroblastoma, Signaling, TrkB
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 75, Issue 1, Pages 131-141
Publisher
Springer Nature
Online
2014-11-15
DOI
10.1007/s00280-014-2627-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic targets for neuroblastomas
- (2014) Garrett M Brodeur et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- (2013) Aria Vaishnavi et al. NATURE MEDICINE
- Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer
- (2012) Y Okugawa et al. BRITISH JOURNAL OF CANCER
- AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts
- (2012) Radhika Iyer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma
- (2011) Wook Jin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
- (2011) Jane E. Minturn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Role and Relevance of TrkB Mutations and Expression in Non-Small Cell Lung Cancer
- (2011) T. Harada et al. CLINICAL CANCER RESEARCH
- More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cells
- (2011) Dawei Guo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Overexpression of TrkB promotes the progression of colon cancer
- (2010) YINGJIAO YU et al. APMIS
- The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan
- (2010) Peter E. Zage et al. CANCER
- TrkC plays an essential role in breast tumor growth and metastasis
- (2010) Wook Jin et al. CARCINOGENESIS
- Lestaurtinib Enhances the Antitumor Efficacy of Chemotherapy in Murine Xenograft Models of Neuroblastoma
- (2010) R. Iyer et al. CLINICAL CANCER RESEARCH
- K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr Virus (EBV)—associated nasopharyngeal carcinoma cells
- (2010) Yuen-Keng Ng et al. INVESTIGATIONAL NEW DRUGS
- On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
- (2009) C. J. Thiele et al. CLINICAL CANCER RESEARCH
- Trk Receptor Expression and Inhibition in Neuroblastomas
- (2009) G. M. Brodeur et al. CLINICAL CANCER RESEARCH
- Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway
- (2009) K. Thress et al. MOLECULAR CANCER THERAPEUTICS
- TrkA overexpression enhances growth and metastasis of breast cancer cells
- (2009) C Lagadec et al. ONCOGENE
- Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer
- (2008) Xiaohui Yu et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now